DPP4 and diabetes mellitus: Recent preclinical studies in mouse models of diabetes have reported the beneficial effects of certain antidiabetic drugs, such as dipeptidyl peptidase-4 (DPP-4) inhibitors and metformin, on neuroinflammation and cognitive impairment [17,18,19].